NEW YORK (GenomeWeb News) – Oxford Gene Technology said today that it has been working with Emory Genetics Laboratory to develop a menu of comparative genomic hybridization arrays focused on a variety of genetic disorders.

Together, the Oxford, UK-based company and EGL have designed more than 20 such chips, which enable the detection of copy number variants in genes associated with cardiovascular, inherited eye, intellectual disability, and neuromuscular disorders, as well as a range of inherited cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.